Global and United States Human Growth Hormone Drugs Market Insights, Forecast to 2026

Publisher Name :
Date: 27-Oct-2020
No. of pages: 132
Inquire Before Buying

Human Growth Hormone Drugs market is segmented by region (country), players, by Type, and by Application. Players, stakeholders, and other participants in the global Human Growth Hormone Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application in terms of revenue and forecast for the period 2015-2026.

Segment by Type, the Human Growth Hormone Drugs market is segmented into

- Norditropin

- Genotropin

- Humatrope

- Saizen

- Omnitrope - the Somatropin Biosimilar

- Somatropin Biopartners

Segment by Application, the Human Growth Hormone Drugs market is segmented into

- Prader-Willi Syndrome

- Turner Syndrome

- Short Stature Homeobox Gene

- Small for Gestational Age

- Chronic Renal Insufficiency

- Short Bowel Syndrome

Regional and Country-level Analysis

The Human Growth Hormone Drugs market is analysed and market size information is provided by regions (countries).

The key regions covered in the Human Growth Hormone Drugs market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.

The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.

Competitive Landscape and Human Growth Hormone Drugs Market Share Analysis

Human Growth Hormone Drugs market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Human Growth Hormone Drugs business, the date to enter into the Human Growth Hormone Drugs market, Human Growth Hormone Drugs product introduction, recent developments, etc.

The major vendors covered:

- Eli Lilly and Company (US)

- Ferring Holding SA (Switzerland)

- Genentech, Inc. (US)

- GeneScience Pharmaceuticals Co., Ltd. (China)

- Merck KgaA (Germany)

- Novo Nordisk A/S (Denmark)

- Pfizer, Inc. (US)

- Sandoz International GmbH (Germany)

Global and United States Human Growth Hormone Drugs Market Insights, Forecast to 2026

Table of Contents
1 Study Coverage
1.1 Human Growth Hormone Drugs Product Introduction
1.2 Market Segments
1.3 Key Human Growth Hormone Drugs Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Human Growth Hormone Drugs Market Size Growth Rate by Type
1.4.2 Norditropin
1.4.3 Genotropin
1.4.4 Humatrope
1.4.5 Saizen
1.4.6 Omnitrope - the Somatropin Biosimilar
1.4.7 Somatropin Biopartners
1.5 Market by Application
1.5.1 Global Human Growth Hormone Drugs Market Size Growth Rate by Application
1.5.2 Prader-Willi Syndrome
1.5.3 Turner Syndrome
1.5.4 Short Stature Homeobox Gene
1.5.5 Small for Gestational Age
1.5.6 Chronic Renal Insufficiency
1.5.7 Short Bowel Syndrome
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Human Growth Hormone Drugs Market Size, Estimates and Forecasts
2.1.1 Global Human Growth Hormone Drugs Revenue 2015-2026
2.1.2 Global Human Growth Hormone Drugs Sales 2015-2026
2.2 Global Human Growth Hormone Drugs, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.3 Human Growth Hormone Drugs Historical Market Size by Region (2015-2020)
2.3.1 Global Human Growth Hormone Drugs Retrospective Market Scenario in Sales by Region: 2015-2020
2.3.2 Global Human Growth Hormone Drugs Retrospective Market Scenario in Revenue by Region: 2015-2020
2.4 Human Growth Hormone Drugs Market Estimates and Projections by Region (2021-2026)
2.4.1 Global Human Growth Hormone Drugs Sales Forecast by Region (2021-2026)
2.4.2 Global Human Growth Hormone Drugs Revenue Forecast by Region (2021-2026)
3 Global Human Growth Hormone Drugs Competitor Landscape by Players
3.1 Global Top Human Growth Hormone Drugs Sales by Manufacturers
3.1.1 Global Human Growth Hormone Drugs Sales by Manufacturers (2015-2020)
3.1.2 Global Human Growth Hormone Drugs Sales Market Share by Manufacturers (2015-2020)
3.2 Global Human Growth Hormone Drugs Manufacturers by Revenue
3.2.1 Global Human Growth Hormone Drugs Revenue by Manufacturers (2015-2020)
3.2.2 Global Human Growth Hormone Drugs Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Human Growth Hormone Drugs Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Human Growth Hormone Drugs Revenue in 2019
3.2.5 Global Human Growth Hormone Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Global Human Growth Hormone Drugs Price by Manufacturers
3.4 Global Human Growth Hormone Drugs Manufacturing Base Distribution, Product Types
3.4.1 Human Growth Hormone Drugs Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Human Growth Hormone Drugs Product Type
3.4.3 Date of International Manufacturers Enter into Human Growth Hormone Drugs Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Human Growth Hormone Drugs Market Size by Type (2015-2020)
4.1.1 Global Human Growth Hormone Drugs Sales by Type (2015-2020)
4.1.2 Global Human Growth Hormone Drugs Revenue by Type (2015-2020)
4.1.3 Human Growth Hormone Drugs Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Human Growth Hormone Drugs Market Size Forecast by Type (2021-2026)
4.2.1 Global Human Growth Hormone Drugs Sales Forecast by Type (2021-2026)
4.2.2 Global Human Growth Hormone Drugs Revenue Forecast by Type (2021-2026)
4.2.3 Human Growth Hormone Drugs Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Human Growth Hormone Drugs Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
5.1 Global Human Growth Hormone Drugs Market Size by Application (2015-2020)
5.1.1 Global Human Growth Hormone Drugs Sales by Application (2015-2020)
5.1.2 Global Human Growth Hormone Drugs Revenue by Application (2015-2020)
5.1.3 Human Growth Hormone Drugs Price by Application (2015-2020)
5.2 Human Growth Hormone Drugs Market Size Forecast by Application (2021-2026)
5.2.1 Global Human Growth Hormone Drugs Sales Forecast by Application (2021-2026)
5.2.2 Global Human Growth Hormone Drugs Revenue Forecast by Application (2021-2026)
5.2.3 Global Human Growth Hormone Drugs Price Forecast by Application (2021-2026)
6 United States by Players, Type and Application
6.1 United States Human Growth Hormone Drugs Market Size YoY Growth 2015-2026
6.1.1 United States Human Growth Hormone Drugs Sales YoY Growth 2015-2026
6.1.2 United States Human Growth Hormone Drugs Revenue YoY Growth 2015-2026
6.1.3 United States Human Growth Hormone Drugs Market Share in Global Market 2015-2026
6.2 United States Human Growth Hormone Drugs Market Size by Players (International and Local Players)
6.2.1 United States Top Human Growth Hormone Drugs Players by Sales (2015-2020)
6.2.2 United States Top Human Growth Hormone Drugs Players by Revenue (2015-2020)
6.3 United States Human Growth Hormone Drugs Historic Market Review by Type (2015-2020)
6.3.1 United States Human Growth Hormone Drugs Sales Market Share by Type (2015-2020)
6.3.2 United States Human Growth Hormone Drugs Revenue Market Share by Type (2015-2020)
6.3.3 United States Human Growth Hormone Drugs Price by Type (2015-2020)
6.4 United States Human Growth Hormone Drugs Market Estimates and Forecasts by Type (2021-2026)
6.4.1 United States Human Growth Hormone Drugs Sales Forecast by Type (2021-2026)
6.4.2 United States Human Growth Hormone Drugs Revenue Forecast by Type (2021-2026)
6.4.3 United States Human Growth Hormone Drugs Price Forecast by Type (2021-2026)
6.5 United States Human Growth Hormone Drugs Historic Market Review by Application (2015-2020)
6.5.1 United States Human Growth Hormone Drugs Sales Market Share by Application (2015-2020)
6.5.2 United States Human Growth Hormone Drugs Revenue Market Share by Application (2015-2020)
6.5.3 United States Human Growth Hormone Drugs Price by Application (2015-2020)
6.6 United States Human Growth Hormone Drugs Market Estimates and Forecasts by Application (2021-2026)
6.6.1 United States Human Growth Hormone Drugs Sales Forecast by Application (2021-2026)
6.6.2 United States Human Growth Hormone Drugs Revenue Forecast by Application (2021-2026)
6.6.3 United States Human Growth Hormone Drugs Price Forecast by Application (2021-2026)
7 North America
7.1 North America Human Growth Hormone Drugs Market Size YoY Growth 2015-2026
7.2 North America Human Growth Hormone Drugs Market Facts & Figures by Country
7.2.1 North America Human Growth Hormone Drugs Sales by Country (2015-2020)
7.2.2 North America Human Growth Hormone Drugs Revenue by Country (2015-2020)
7.2.3 U.S.
7.2.4 Canada
8 Europe
8.1 Europe Human Growth Hormone Drugs Market Size YoY Growth 2015-2026
8.2 Europe Human Growth Hormone Drugs Market Facts & Figures by Country
8.2.1 Europe Human Growth Hormone Drugs Sales by Country
8.2.2 Europe Human Growth Hormone Drugs Revenue by Country
8.2.3 Germany
8.2.4 France
8.2.5 U.K.
8.2.6 Italy
8.2.7 Russia
9 Asia Pacific
9.1 Asia Pacific Human Growth Hormone Drugs Market Size YoY Growth 2015-2026
9.2 Asia Pacific Human Growth Hormone Drugs Market Facts & Figures by Country
9.2.1 Asia Pacific Human Growth Hormone Drugs Sales by Region (2015-2020)
9.2.2 Asia Pacific Human Growth Hormone Drugs Revenue by Region
9.2.3 China
9.2.4 Japan
9.2.5 South Korea
9.2.6 India
9.2.7 Australia
9.2.8 Taiwan
9.2.9 Indonesia
9.2.10 Thailand
9.2.11 Malaysia
9.2.12 Philippines
9.2.13 Vietnam
10 Latin America
10.1 Latin America Human Growth Hormone Drugs Market Size YoY Growth 2015-2026
10.2 Latin America Human Growth Hormone Drugs Market Facts & Figures by Country
10.2.1 Latin America Human Growth Hormone Drugs Sales by Country
10.2.2 Latin America Human Growth Hormone Drugs Revenue by Country
10.2.3 Mexico
10.2.4 Brazil
10.2.5 Argentina
11 Middle East and Africa
11.1 Middle East and Africa Human Growth Hormone Drugs Market Size YoY Growth 2015-2026
11.2 Middle East and Africa Human Growth Hormone Drugs Market Facts & Figures by Country
11.2.1 Middle East and Africa Human Growth Hormone Drugs Sales by Country
11.2.2 Middle East and Africa Human Growth Hormone Drugs Revenue by Country
11.2.3 Turkey
11.2.4 Saudi Arabia
11.2.5 U.A.E
12 Company Profiles
12.1 Eli Lilly and Company (US)
12.1.1 Eli Lilly and Company (US) Corporation Information
12.1.2 Eli Lilly and Company (US) Description and Business Overview
12.1.3 Eli Lilly and Company (US) Sales, Revenue and Gross Margin (2015-2020)
12.1.4 Eli Lilly and Company (US) Human Growth Hormone Drugs Products Offered
12.1.5 Eli Lilly and Company (US) Recent Development
12.2 Ferring Holding SA (Switzerland)
12.2.1 Ferring Holding SA (Switzerland) Corporation Information
12.2.2 Ferring Holding SA (Switzerland) Description and Business Overview
12.2.3 Ferring Holding SA (Switzerland) Sales, Revenue and Gross Margin (2015-2020)
12.2.4 Ferring Holding SA (Switzerland) Human Growth Hormone Drugs Products Offered
12.2.5 Ferring Holding SA (Switzerland) Recent Development
12.3 Genentech, Inc. (US)
12.3.1 Genentech, Inc. (US) Corporation Information
12.3.2 Genentech, Inc. (US) Description and Business Overview
12.3.3 Genentech, Inc. (US) Sales, Revenue and Gross Margin (2015-2020)
12.3.4 Genentech, Inc. (US) Human Growth Hormone Drugs Products Offered
12.3.5 Genentech, Inc. (US) Recent Development
12.4 GeneScience Pharmaceuticals Co., Ltd. (China)
12.4.1 GeneScience Pharmaceuticals Co., Ltd. (China) Corporation Information
12.4.2 GeneScience Pharmaceuticals Co., Ltd. (China) Description and Business Overview
12.4.3 GeneScience Pharmaceuticals Co., Ltd. (China) Sales, Revenue and Gross Margin (2015-2020)
12.4.4 GeneScience Pharmaceuticals Co., Ltd. (China) Human Growth Hormone Drugs Products Offered
12.4.5 GeneScience Pharmaceuticals Co., Ltd. (China) Recent Development
12.5 Merck KgaA (Germany)
12.5.1 Merck KgaA (Germany) Corporation Information
12.5.2 Merck KgaA (Germany) Description and Business Overview
12.5.3 Merck KgaA (Germany) Sales, Revenue and Gross Margin (2015-2020)
12.5.4 Merck KgaA (Germany) Human Growth Hormone Drugs Products Offered
12.5.5 Merck KgaA (Germany) Recent Development
12.6 Novo Nordisk A/S (Denmark)
12.6.1 Novo Nordisk A/S (Denmark) Corporation Information
12.6.2 Novo Nordisk A/S (Denmark) Description and Business Overview
12.6.3 Novo Nordisk A/S (Denmark) Sales, Revenue and Gross Margin (2015-2020)
12.6.4 Novo Nordisk A/S (Denmark) Human Growth Hormone Drugs Products Offered
12.6.5 Novo Nordisk A/S (Denmark) Recent Development
12.7 Pfizer, Inc. (US)
12.7.1 Pfizer, Inc. (US) Corporation Information
12.7.2 Pfizer, Inc. (US) Description and Business Overview
12.7.3 Pfizer, Inc. (US) Sales, Revenue and Gross Margin (2015-2020)
12.7.4 Pfizer, Inc. (US) Human Growth Hormone Drugs Products Offered
12.7.5 Pfizer, Inc. (US) Recent Development
12.8 Sandoz International GmbH (Germany)
12.8.1 Sandoz International GmbH (Germany) Corporation Information
12.8.2 Sandoz International GmbH (Germany) Description and Business Overview
12.8.3 Sandoz International GmbH (Germany) Sales, Revenue and Gross Margin (2015-2020)
12.8.4 Sandoz International GmbH (Germany) Human Growth Hormone Drugs Products Offered
12.8.5 Sandoz International GmbH (Germany) Recent Development
12.11 Eli Lilly and Company (US)
12.11.1 Eli Lilly and Company (US) Corporation Information
12.11.2 Eli Lilly and Company (US) Description and Business Overview
12.11.3 Eli Lilly and Company (US) Sales, Revenue and Gross Margin (2015-2020)
12.11.4 Eli Lilly and Company (US) Human Growth Hormone Drugs Products Offered
12.11.5 Eli Lilly and Company (US) Recent Development
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter's Five Forces Analysis
13.5 Primary Interviews with Key Human Growth Hormone Drugs Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Human Growth Hormone Drugs Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
List of Tables
Table 1. Human Growth Hormone Drugs Market Segments
Table 2. Ranking of Global Top Human Growth Hormone Drugs Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Human Growth Hormone Drugs Market Size Growth Rate by Type 2020-2026 (K Pcs) & (US$ Million)
Table 4. Major Manufacturers of Norditropin
Table 5. Major Manufacturers of Genotropin
Table 6. Major Manufacturers of Humatrope
Table 7. Major Manufacturers of Saizen
Table 8. Major Manufacturers of Omnitrope - the Somatropin Biosimilar
Table 9. Major Manufacturers of Somatropin Biopartners
Table 10. Global Human Growth Hormone Drugs Market Size Growth Rate by Application 2020-2026 (K Pcs)
Table 11. Global Human Growth Hormone Drugs Market Size by Region (K Pcs) & (US$ Million): 2020 VS 2026
Table 12. Global Human Growth Hormone Drugs Sales by Regions 2015-2020 (K Pcs)
Table 13. Global Human Growth Hormone Drugs Sales Market Share by Regions (2015-2020)
Table 14. Global Human Growth Hormone Drugs Revenue by Regions 2015-2020 (US$ Million)
Table 15. Global Human Growth Hormone Drugs Sales Forecast by Region (2021-2026) (K Pcs)
Table 16. Global Human Growth Hormone Drugs Sales by Manufacturers (2015-2020) (K Pcs)
Table 17. Global Human Growth Hormone Drugs Sales Share by Manufacturers (2015-2020)
Table 18. Global Human Growth Hormone Drugs Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 19. Global Human Growth Hormone Drugs by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Human Growth Hormone Drugs as of 2019)
Table 20. Human Growth Hormone Drugs Revenue by Manufacturers (2015-2020) (US$ Million)
Table 21. Human Growth Hormone Drugs Revenue Share by Manufacturers (2015-2020)
Table 22. Key Manufacturers Human Growth Hormone Drugs Price (2015-2020) (USD/Pcs)
Table 23. Human Growth Hormone Drugs Manufacturers Manufacturing Base Distribution and Headquarters
Table 24. Manufacturers Human Growth Hormone Drugs Product Type
Table 25. Date of International Manufacturers Enter into Human Growth Hormone Drugs Market
Table 26. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 27. Global Human Growth Hormone Drugs Sales by Type (2015-2020) (K Pcs)
Table 28. Global Human Growth Hormone Drugs Sales Share by Type (2015-2020)
Table 29. Global Human Growth Hormone Drugs Revenue by Type (2015-2020) (US$ Million)
Table 30. Global Human Growth Hormone Drugs Revenue Share by Type (2015-2020)
Table 31. Human Growth Hormone Drugs Average Selling Price (ASP) by Type 2015-2020 (USD/Pcs)
Table 32. Global Human Growth Hormone Drugs Sales Share by Type (2021-2026)
Table 33. Global Human Growth Hormone Drugs Sales by Application (2015-2020) (K Pcs)
Table 34. Global Human Growth Hormone Drugs Sales Share by Application (2015-2020)
Table 35. Global Human Growth Hormone Drugs Sales Share by Application (2021-2026)
Table 36. Global Human Growth Hormone Drugs Sales Market Share Forecast by Application (2021-2026)
Table 37. Global Human Growth Hormone Drugs Revenue by Application (2015-2020) (US$ Million)
Table 38. Global Human Growth Hormone Drugs Revenue Market Share Forecast by Application (2021-2026)
Table 39. United States Human Growth Hormone Drugs Sales (K Pcs) of Key Companies (2015-2020)
Table 40. United States Human Growth Hormone Drugs Sales Share by Company (2015-2020)
Table 41. United States Human Growth Hormone Drugs Revenue (US$ Million) by Company (2015-2020)
Table 42. United States Human Growth Hormone Drugs Sales (K Pcs) by Type (2015-2020)
Table 43. United States Human Growth Hormone Drugs Sales Share by Type (2015-2020)
Table 44. United States Human Growth Hormone Drugs Revenue (US$ Million) Market Share by Type (2015-2020)
Table 45. United States Human Growth Hormone Drugs Price (K Pcs) by Type (2015-2020)
Table 46. United States Human Growth Hormone Drugs Sales (K Pcs) by Type (2021-2026)
Table 47. United States Human Growth Hormone Drugs Sales Share by Type (2021-2026)
Table 48. United States Human Growth Hormone Drugs Revenue (US$ Million) Market Share by Type (2021-2026)
Table 49. United States Human Growth Hormone Drugs Revenue Share by Type (2021-2026)
Table 50. United States Human Growth Hormone Drugs Price (K Pcs) by Type (2021-2026)
Table 51. United States Human Growth Hormone Drugs Sales (K Pcs) by Application (2015-2020)
Table 52. United States Human Growth Hormone Drugs Sales Share by Application (2015-2020)
Table 53. United States Human Growth Hormone Drugs Revenue (US$ Million) Market Share by Application (2015-2020)
Table 54. United States Human Growth Hormone Drugs Sales (K Pcs) by Application (2021-2026)
Table 55. United States Human Growth Hormone Drugs Sales Share by Application (2021-2026)
Table 56. United States Human Growth Hormone Drugs Revenue (US$ Million) Market Share by Application (2021-2026)
Table 57. United States Human Growth Hormone Drugs Revenue Share by Application (2021-2026)
Table 58. North America Human Growth Hormone Drugs Sales by Country (2015-2020) (K Pcs)
Table 59. North America Human Growth Hormone Drugs Sales Market Share by Country (2015-2020)
Table 60. North America Human Growth Hormone Drugs Revenue by Country (2015-2020) (US$ Million)
Table 61. North America Human Growth Hormone Drugs Revenue Market Share by Country (2015-2020)
Table 62. Europe Human Growth Hormone Drugs Sales by Country (2015-2020) (K Pcs)
Table 63. Europe Human Growth Hormone Drugs Sales Market Share by Country (2015-2020)
Table 64. Europe Human Growth Hormone Drugs Revenue by Country (2015-2020) (US$ Million)
Table 65. Europe Human Growth Hormone Drugs Revenue Market Share by Country (2015-2020)
Table 66. Asia Pacific Human Growth Hormone Drugs Sales by Region (2015-2020) (K Pcs)
Table 67. Asia Pacific Human Growth Hormone Drugs Sales Market Share by Region (2015-2020)
Table 68. Asia Pacific Human Growth Hormone Drugs Revenue by Region (2015-2020) (US$ Million)
Table 69. Asia Pacific Human Growth Hormone Drugs Revenue Market Share by Region (2015-2020)
Table 70. Latin America Human Growth Hormone Drugs Sales by Country (2015-2020) (K Pcs)
Table 71. Latin America Human Growth Hormone Drugs Sales Market Share by Country (2015-2020)
Table 72. Latin Americaa Human Growth Hormone Drugs Revenue by Country (2015-2020) (US$ Million)
Table 73. Latin America Human Growth Hormone Drugs Revenue Market Share by Country (2015-2020)
Table 74. Middle East and Africa Human Growth Hormone Drugs Sales by Country (2015-2020) (K Pcs)
Table 75. Middle East and Africa Human Growth Hormone Drugs Sales Market Share by Country (2015-2020)
Table 76. Middle East and Africa Human Growth Hormone Drugs Revenue by Country (2015-2020) (US$ Million)
Table 77. Middle East and Africa Human Growth Hormone Drugs Revenue Market Share by Country (2015-2020)
Table 78. Eli Lilly and Company (US) Corporation Information
Table 79. Eli Lilly and Company (US) Description and Business Overview
Table 80. Eli Lilly and Company (US) Human Growth Hormone Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 81. Eli Lilly and Company (US) Human Growth Hormone Drugs Product
Table 82. Eli Lilly and Company (US) Recent Development
Table 83. Ferring Holding SA (Switzerland) Corporation Information
Table 84. Ferring Holding SA (Switzerland) Description and Business Overview
Table 85. Ferring Holding SA (Switzerland) Human Growth Hormone Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 86. Ferring Holding SA (Switzerland) Product
Table 87. Ferring Holding SA (Switzerland) Recent Development
Table 88. Genentech, Inc. (US) Corporation Information
Table 89. Genentech, Inc. (US) Description and Business Overview
Table 90. Genentech, Inc. (US) Human Growth Hormone Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 91. Genentech, Inc. (US) Product
Table 92. Genentech, Inc. (US) Recent Development
Table 93. GeneScience Pharmaceuticals Co., Ltd. (China) Corporation Information
Table 94. GeneScience Pharmaceuticals Co., Ltd. (China) Description and Business Overview
Table 95. GeneScience Pharmaceuticals Co., Ltd. (China) Human Growth Hormone Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 96. GeneScience Pharmaceuticals Co., Ltd. (China) Product
Table 97. GeneScience Pharmaceuticals Co., Ltd. (China) Recent Development
Table 98. Merck KgaA (Germany) Corporation Information
Table 99. Merck KgaA (Germany) Description and Business Overview
Table 100. Merck KgaA (Germany) Human Growth Hormone Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 101. Merck KgaA (Germany) Product
Table 102. Merck KgaA (Germany) Recent Development
Table 103. Novo Nordisk A/S (Denmark) Corporation Information
Table 104. Novo Nordisk A/S (Denmark) Description and Business Overview
Table 105. Novo Nordisk A/S (Denmark) Human Growth Hormone Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 106. Novo Nordisk A/S (Denmark) Product
Table 107. Novo Nordisk A/S (Denmark) Recent Development
Table 108. Pfizer, Inc. (US) Corporation Information
Table 109. Pfizer, Inc. (US) Description and Business Overview
Table 110. Pfizer, Inc. (US) Human Growth Hormone Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 111. Pfizer, Inc. (US) Product
Table 112. Pfizer, Inc. (US) Recent Development
Table 113. Sandoz International GmbH (Germany) Corporation Information
Table 114. Sandoz International GmbH (Germany) Description and Business Overview
Table 115. Sandoz International GmbH (Germany) Human Growth Hormone Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 116. Sandoz International GmbH (Germany) Product
Table 117. Sandoz International GmbH (Germany) Recent Development
Table 118. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 119. Key Challenges
Table 120. Market Risks
Table 121. Main Points Interviewed from Key Human Growth Hormone Drugs Players
Table 122. Human Growth Hormone Drugs Customers List
Table 123. Human Growth Hormone Drugs Distributors List
Table 124. Research Programs/Design for This Report
Table 125. Key Data Information from Secondary Sources
Table 126. Key Data Information from Primary Sources
List of Figures
Figure 1. Human Growth Hormone Drugs Product Picture
Figure 2. Global Human Growth Hormone Drugs Sales Market Share by Type in 2020 & 2026
Figure 3. Norditropin Product Picture
Figure 4. Genotropin Product Picture
Figure 5. Humatrope Product Picture
Figure 6. Saizen Product Picture
Figure 7. Omnitrope - the Somatropin Biosimilar Product Picture
Figure 8. Somatropin Biopartners Product Picture
Figure 9. Global Human Growth Hormone Drugs Sales Market Share by Application in 2020 & 2026
Figure 10. Prader-Willi Syndrome
Figure 11. Turner Syndrome
Figure 12. Short Stature Homeobox Gene
Figure 13. Small for Gestational Age
Figure 14. Chronic Renal Insufficiency
Figure 15. Short Bowel Syndrome
Figure 16. Human Growth Hormone Drugs Report Years Considered
Figure 17. Global Human Growth Hormone Drugs Market Size 2015-2026 (US$ Million)
Figure 18. Global Human Growth Hormone Drugs Sales 2015-2026 (K Pcs)
Figure 19. Global Human Growth Hormone Drugs Market Size Market Share by Region: 2020 Versus 2026
Figure 20. Global Human Growth Hormone Drugs Sales Market Share by Region (2015-2020)
Figure 21. Global Human Growth Hormone Drugs Sales Market Share by Region in 2019
Figure 22. Global Human Growth Hormone Drugs Revenue Market Share by Region (2015-2020)
Figure 23. Global Human Growth Hormone Drugs Revenue Market Share by Region in 2019
Figure 24. Global Human Growth Hormone Drugs Sales Share by Manufacturer in 2019
Figure 25. The Top 10 and 5 Players Market Share by Human Growth Hormone Drugs Revenue in 2019
Figure 26. Human Growth Hormone Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 27. Global Human Growth Hormone Drugs Sales Market Share by Type (2015-2020)
Figure 28. Global Human Growth Hormone Drugs Sales Market Share by Type in 2019
Figure 29. Global Human Growth Hormone Drugs Revenue Market Share by Type (2015-2020)
Figure 30. Global Human Growth Hormone Drugs Revenue Market Share by Type in 2019
Figure 31. Global Human Growth Hormone Drugs Market Share by Price Range (2015-2020)
Figure 32. Global Human Growth Hormone Drugs Sales Market Share by Application (2015-2020)
Figure 33. Global Human Growth Hormone Drugs Sales Market Share by Application in 2019
Figure 34. Global Human Growth Hormone Drugs Revenue Market Share by Application (2015-2020)
Figure 35. Global Human Growth Hormone Drugs Revenue Market Share by Application in 2019
Figure 36. United States Human Growth Hormone Drugs Sales Growth Rate 2015-2026 (K Pcs)
Figure 37. United States Human Growth Hormone Drugs Revenue Growth Rate 2015-2026 (US$ Million)
Figure 38. United States Human Growth Hormone Drugs Market Share in Global Market 2015-2026
Figure 39. United States 5 and 10 Largest Human Growth Hormone Drugs Players Market Share by Revenue in Human Growth Hormone Drugs in 2019
Figure 40. United States Human Growth Hormone Drugs Revenue Share by Type (2015-2020)
Figure 41. United States Human Growth Hormone Drugs Revenue Growth Rate by Type in 2015 & 2019
Figure 42. United States Human Growth Hormone Drugs Revenue Share by Application (2015-2020)
Figure 43. United States Human Growth Hormone Drugs Revenue Growth Rate by Application in 2015 & 2019
Figure 44. North America Human Growth Hormone Drugs Sales Growth Rate 2015-2020 (K Pcs)
Figure 45. North America Human Growth Hormone Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 46. North America Human Growth Hormone Drugs Sales Market Share by Country in 2019
Figure 47. North America Human Growth Hormone Drugs Revenue Market Share by Country in 2019
Figure 48. U.S. Human Growth Hormone Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 49. U.S. Human Growth Hormone Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 50. Canada Human Growth Hormone Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 51. Canada Human Growth Hormone Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 52. Europe Human Growth Hormone Drugs Sales Growth Rate 2015-2020 (K Pcs)
Figure 53. Europe Human Growth Hormone Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 54. Europe Human Growth Hormone Drugs Sales Market Share by Country in 2019
Figure 55. Europe Human Growth Hormone Drugs Revenue Market Share by Country in 2019
Figure 56. Germany Human Growth Hormone Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 57. Germany Human Growth Hormone Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 58. France Human Growth Hormone Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 59. France Human Growth Hormone Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 60. U.K. Human Growth Hormone Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 61. U.K. Human Growth Hormone Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 62. Italy Human Growth Hormone Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 63. Italy Human Growth Hormone Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 64. Russia Human Growth Hormone Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 65. Russia Human Growth Hormone Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 66. Asia Pacific Human Growth Hormone Drugs Sales Growth Rate 2015-2020 (K Pcs)
Figure 67. Asia Pacific Human Growth Hormone Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 68. Asia Pacific Human Growth Hormone Drugs Sales Market Share by Region in 2019
Figure 69. Asia Pacific Human Growth Hormone Drugs Revenue Market Share by Region in 2019
Figure 70. China Human Growth Hormone Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 71. China Human Growth Hormone Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 72. Japan Human Growth Hormone Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 73. Japan Human Growth Hormone Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 74. South Korea Human Growth Hormone Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 75. South Korea Human Growth Hormone Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 76. India Human Growth Hormone Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 77. India Human Growth Hormone Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 78. Australia Human Growth Hormone Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 79. Australia Human Growth Hormone Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 80. Taiwan Human Growth Hormone Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 81. Taiwan Human Growth Hormone Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 82. Indonesia Human Growth Hormone Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 83. Indonesia Human Growth Hormone Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 84. Thailand Human Growth Hormone Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 85. Thailand Human Growth Hormone Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 86. Malaysia Human Growth Hormone Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 87. Malaysia Human Growth Hormone Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 88. Philippines Human Growth Hormone Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 89. Philippines Human Growth Hormone Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 90. Vietnam Human Growth Hormone Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 91. Vietnam Human Growth Hormone Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 92. Latin America Human Growth Hormone Drugs Sales Growth Rate 2015-2020 (K Pcs)
Figure 93. Latin America Human Growth Hormone Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 94. Latin America Human Growth Hormone Drugs Sales Market Share by Country in 2019
Figure 95. Latin America Human Growth Hormone Drugs Revenue Market Share by Country in 2019
Figure 96. Mexico Human Growth Hormone Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 97. Mexico Human Growth Hormone Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 98. Brazil Human Growth Hormone Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 99. Brazil Human Growth Hormone Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 100. Argentina Human Growth Hormone Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 101. Argentina Human Growth Hormone Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 102. Middle East and Africa Human Growth Hormone Drugs Sales Growth Rate 2015-2020 (K Pcs)
Figure 103. Middle East and Africa Human Growth Hormone Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 104. Middle East and Africa Human Growth Hormone Drugs Sales Market Share by Country in 2019
Figure 105. Middle East and Africa Human Growth Hormone Drugs Revenue Market Share by Country in 2019
Figure 106. Turkey Human
  • Global Antioxidant Vitamins Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 100
    The global Antioxidant Vitamins market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ millio......
  • Global Clavulanate Potassium Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86
    The global Clavulanate Potassium market was valued at US$ 446.6 million in 2023 and is anticipated to reach US$ 637.2 million by 2030, witnessing a CAGR of 5.2% during The forecast period 2024-2030. North American market for Clavulanate Potassium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Clavulanate Potassium is estimated to increase from $ million in 2023......
  • Global Amoxicillin Sodium Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 84
    The global Amoxicillin Sodium market was valued at US$ 460.9 million in 2023 and is anticipated to reach US$ 735.1 million by 2030, witnessing a CAGR of 7.0% during The forecast period 2024-2030. North American market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach......
  • Global Melatonin Supplements Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106
    The global Melatonin Supplements market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ mil......
  • Global Sleeping Pills (Prescription Drugs) Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 93
    The global Sleeping Pills (Prescription Drugs) market was valued at US$ 1022.3 million in 2023 and is anticipated to reach US$ 1437.8 million by 2030, witnessing a CAGR of 4.9% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical......
  • Global Sleeping Pills Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94
    The global Sleeping Pills market was valued at US$ 2042.3 million in 2023 and is anticipated to reach US$ 2979.5 million by 2030, witnessing a CAGR of 3.8% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......
  • Global Zinc Oral Drops Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85
    The global Zinc Oral Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a......
  • Global Zinc Drops Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85
    The global Zinc Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % duri......
  • Global Anti-Infectives Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 78
    The global Anti-Infectives market was valued at US$ 22700 million in 2023 and is anticipated to reach US$ 27480 million by 2030, witnessing a CAGR of 2.3% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estima......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs